Evestia Clinical is a specialised, full-service global Clinical Research Organization that offers market-leading experience and expertise to pharmaceutical and biotech companies. Evestia Clinical provides bespoke and tailored clinical trial services across therapeutic areas, including oncology, rare disease, inflammation, immunology and microbiome therapeutics. Evestia Clinical, previously known as EMAS Pharma, was acquired by Kester Capital in December 2024.
Company Details
- Employees
- 73
- Founded
- -
- Address
- Evestia Clinical Limited, Suite 209, Spirella Building, Bridge Road, Letchworth Garden City, Hertfordshire, Sg6 4et, Hertfordshire,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Hertfordshire
Evestia Clinical Questions
Evestia Clinical's LinkedIn profile is https://uk.linkedin.com/company/evestiaclinical
Evestia Clinical has
73 employees.
View email and phone details for 73
employees at Evestia Clinical.
Evestia Clinical's industry is
Biotechnology Research
Evestia Clinical's top competitors are
Kester Capital,
Worldwide Clinical Trials,
Comac Medical,
Ergomed,
Bionical Emas,
Hvivo,
Atlantic Research Group,
Fusion Group,
Biomapas,
Clerkenwell Health.
Evestia Clinical's categories are Biotechnology Research
Evestia Clinical's founding year is 1996
